4//SEC Filing
GOTTSCHALK ADRIAN 4
Accession 0001562180-22-006726
CIK 0001822462other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:06 PM ET
Size
8.1 KB
Accession
0001562180-22-006726
Insider Transaction Report
Form 4
GOTTSCHALK ADRIAN
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-09-16−40,000→ 418,925 totalExercise: $0.54Exp: 2027-05-29→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2022-09-16$0.54/sh+40,000$21,600→ 186,479 total
Holdings
- 325,225(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Consists of 300,000 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 25,225 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee.
- [F2]The option vested as to 25% of the underlying shares of common stock on May 30, 2018, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option was fully vested.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001828724
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:06 PM ET
- Size
- 8.1 KB